Tutorial showing how to create awesome, word cloud text portrait designs that are filled with custom text. You can use the ...

Stuhr Museum invites the public to experience a “once in a lifetime” artistic event this week as internationally celebrated ...

Matt Parker has built a career out of making mathematics marvellously merry. Getting Triggy With It proves that when it comes ...

A big part of Biogen's efforts to defend its spinal muscular atrophy (SMA) business has been dealt a setback by the FDA, which declined to approve a high-dose version of its flagship Spinraza product.

Netherlands-based argenx has published positive topline results from its ADAPT SERON trial of its market-leading drug for generalised myasthenia gravis (gMG) Vyvgart (efgartigimod). Significantly, the ...